208 related articles for article (PubMed ID: 10365739)
1. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile.
Galli M; Finazzi G; Norbis F; Marziali S; Marchioli R; Barbui T
Thromb Haemost; 1999 May; 81(5):695-700. PubMed ID: 10365739
[TBL] [Abstract][Full Text] [Related]
2. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C.
Galli M; Ruggeri L; Barbui T
Blood; 1998 Mar; 91(6):1999-2004. PubMed ID: 9490682
[TBL] [Abstract][Full Text] [Related]
5. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
6. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
Court EL
Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
[TBL] [Abstract][Full Text] [Related]
7. Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time.
Olteanu H; Downes KA; Patel J; Praprotnik D; Sarode R
Clin Lab; 2009; 55(3-4):138-42. PubMed ID: 19462936
[TBL] [Abstract][Full Text] [Related]
8. [The positive rate of lupus anticoagulant according to the each understanding disease in our hospital].
Omote M; Yoshida T; Asakura H; Ontachi Y; Hayashi T; Morishita E; Yamazaki M; Fujita S; Nakao S
Rinsho Byori; 2006 Sep; 54(9):903-9. PubMed ID: 17063871
[TBL] [Abstract][Full Text] [Related]
9. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy.
Jouhikainen T
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242
[TBL] [Abstract][Full Text] [Related]
10. Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.
Ferro D; Saliola M; Quintarelli C; Valesini G; Basili S; Grandilli AM; Bonavita MS; Violi F
J Clin Pathol; 1992 Apr; 45(4):332-8. PubMed ID: 1577971
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies].
Barbui T; Finazzi G; Galli M
Ann Ital Med Int; 1997; 12(2):76-83. PubMed ID: 9333316
[TBL] [Abstract][Full Text] [Related]
12. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
Galli M; Finazzi G; Bevers EM; Barbui T
Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
[TBL] [Abstract][Full Text] [Related]
13. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
Pengo V; Biasiolo A; Rampazzo P; Brocco T
Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of silica clotting time for detection of lupus anticoagulants].
Lee HR; Kim JE; Ha SH; Kim HK; Park S; Cho HI
Korean J Lab Med; 2009 Dec; 29(6):497-504. PubMed ID: 20046079
[TBL] [Abstract][Full Text] [Related]
15. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
[TBL] [Abstract][Full Text] [Related]
16. [Detection of lupus anticoagulant using a modified diluted Russell's viper venom time test].
Sato K; Kagami K; Asai M; Nakashima N; Takamatsu J
Rinsho Byori; 1995 Mar; 43(3):263-8. PubMed ID: 7745832
[TBL] [Abstract][Full Text] [Related]
17. Lupus anticoagulants: diagnostic dilemma and clinical challenge.
Triplett DA
Clin Lab Sci; 1997; 10(4):223-8. PubMed ID: 10169622
[TBL] [Abstract][Full Text] [Related]
18. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
19. Protean clinical presentation of antiphospholipid-protein antibodies (APA).
Triplett DA
Thromb Haemost; 1995 Jul; 74(1):329-37. PubMed ID: 8578480
[TBL] [Abstract][Full Text] [Related]
20. Practice and performance of lupus anticoagulant tests: A single centre experience.
Tay Za K; Jayaranee S; Shanmugam H
Malays J Pathol; 2020 Apr; 42(1):51-57. PubMed ID: 32342930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]